Investors seeking shelter from a potential recession may consider CVS Health and Gilead Sciences, two healthcare dividend stocks with defensive business models. CVS Health operates a diversified healthcare business spanning pharmacy, insurance, and pharmacy benefits management, which tends to see steady demand even during economic downturns; it offers a forward dividend yield of 2.6% and has raised payouts by 56.5% over the past decade. Gilead Sciences is a leading drugmaker with a dominant HIV franchise and a growing oncology portfolio, ensuring consistent demand for its therapies; it provides a forward yield of 2.4% and has increased dividends by 74.5% over the past 10 years. Both companies have competitive advantages and long-term growth prospects tied to aging populations and rising healthcare spending.
CVS Health CorpArticle highlights CVS Health's defensive business with steady demand for healthcare services during recessions.
Gilead Sciences IncArticle highlights Gilead's dominant HIV franchise and oncology portfolio ensuring consistent demand for therapies.
NVIDIA Corporation